Bratton Capital Inc., 10% Owner at Denali Therapeutics Inc. (DNLI), sold 129,248 shares at $80.05 ($10.4M) on 2020-12-11, disclosed to the SEC on 2020-12-15.
Open-market sale of $10.4M DNLI by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.05 | 46,799 | $3.7M | 36.2% |
| 2 | $80.05 | 46,799 | $3.7M | 36.2% |
| 3 | $80.35 | 16,949 | $1.4M | 13.1% |
| 4 | $80.35 | 16,949 | $1.4M | 13.1% |
| 5 | $81.13 | 876 | $71K | 0.7% |
| 6 | $81.13 | 876 |
| $71K |
| 0.7% |
| Total | $80.14 avg | 129,248 | $10.4M | 100% |